Neural stem cell biology may be well suited for improving brain tumor therapies.

PubWeight™: 1.05‹?› | Rank: Top 15%

🔗 View Article (PMID 12952304)

Published in Cancer J on September 03, 2003

Authors

Stephen Yip1, Karen S Aboody, Michael Burns, Jaime Imitola, John A Boockvar, Jennifer Allport, Kook In Park, Yang D Teng, Mahesh Lachyankar, Tracy McIntosh, Donald M O'Rourke, Samia Khoury, Ralph Weissleder, Peter M Black, William Weiss, Evan Y Snyder

Author Affiliations

1: The Burnham Institute, Program in Developmental & Regenerative Cell Biology, La Jolla, California 92037, USA.

Articles citing this

Chemokines regulate the migration of neural progenitors to sites of neuroinflammation. J Neurosci (2006) 1.96

Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury. J Clin Invest (2004) 1.85

The chemokine stromal cell-derived factor-1 regulates the migration of sensory neuron progenitors. J Neurosci (2005) 1.69

Targeting of melanoma brain metastases using engineered neural stem/progenitor cells. Neuro Oncol (2006) 1.57

Iron labeling and pre-clinical MRI visualization of therapeutic human neural stem cells in a murine glioma model. PLoS One (2009) 1.36

Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma. Neuro Oncol (2010) 1.04

Stem cell transplantation in brain tumors: a new field for molecular imaging? Mol Med (2010) 0.99

Applications of neural and mesenchymal stem cells in the treatment of gliomas. Expert Rev Anticancer Ther (2009) 0.97

Concise review: Nanoparticles and cellular carriers-allies in cancer imaging and cellular gene therapy? Stem Cells (2010) 0.92

Gene therapy trials for the treatment of high-grade gliomas. Gene Ther Mol Biol (2007) 0.88

MMP-2 mediates mesenchymal stem cell tropism towards medulloblastoma tumors. Gene Ther (2011) 0.86

Selective migration of neuralized embryonic stem cells to stem cell factor and media conditioned by glioma cell lines. Cancer Cell Int (2006) 0.83

Feasibility of cell therapy in multiple sclerosis: a systematic review of 83 studies. Int J Hematol Oncol Stem Cell Res (2013) 0.83

NEURO-ONCOLOGIC PHYSICAL THERAPY FOR THE OLDER PERSON. Top Geriatr Rehabil (2011) 0.78

MMP14 as a novel downstream target of VEGFR2 in migratory glioma-tropic neural stem cells. Stem Cell Res (2015) 0.77

Convergence of normal stem cell and cancer stem cell developmental stage: Implication for differential therapies. World J Stem Cells (2011) 0.76

Potential of neural stem cells for the treatment of brain tumors. Clin Med Oncol (2008) 0.75

Articles by these authors

Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature (2002) 15.36

Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers. Nat Med (2008) 14.47

Restoration of p53 function leads to tumour regression in vivo. Nature (2007) 12.62

The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med (2007) 11.51

Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science (2009) 10.47

Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol (2007) 9.67

Looking and listening to light: the evolution of whole-body photonic imaging. Nat Biotechnol (2005) 9.57

Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med (2003) 9.09

Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest (2007) 8.65

The transcriptional network for mesenchymal transformation of brain tumours. Nature (2009) 8.44

Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res (2003) 8.06

IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature (2012) 7.95

The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol (2005) 7.80

Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell (2012) 7.36

IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat Immunol (2008) 6.41

Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol (2002) 6.06

Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther (2005) 6.04

Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. Proc Natl Acad Sci U S A (2006) 5.90

Fluorescence molecular tomography resolves protease activity in vivo. Nat Med (2002) 5.53

The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies. Cancer Cell (2006) 5.34

Arthritis critically dependent on innate immune system players. Immunity (2002) 5.31

Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell (2002) 5.11

The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell (2010) 5.11

Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci U S A (2004) 4.70

Myocardial infarction accelerates atherosclerosis. Nature (2012) 4.48

Direct reprogramming of human neural stem cells by OCT4. Nature (2009) 4.32

Chip-NMR biosensor for detection and molecular analysis of cells. Nat Med (2008) 4.29

Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation (2007) 4.20

Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med (2013) 4.14

Magnetic relaxation switches capable of sensing molecular interactions. Nat Biotechnol (2002) 4.13

Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. Proc Natl Acad Sci U S A (2004) 4.12

Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. Nat Med (2012) 4.11

A spatially and temporally restricted mouse model of soft tissue sarcoma. Nat Med (2007) 3.96

Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol (2011) 3.95

Tetrazine-based cycloadditions: application to pretargeted live cell imaging. Bioconjug Chem (2008) 3.93

Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity (2006) 3.92

Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation (2007) 3.85

Fast and sensitive pretargeted labeling of cancer cells through a tetrazine/trans-cyclooctene cycloaddition. Angew Chem Int Ed Engl (2009) 3.63

Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation (2006) 3.57

Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation (2007) 3.51

Molecular imaging in drug discovery and development. Nat Rev Drug Discov (2003) 3.44

Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease. Proc Natl Acad Sci U S A (2006) 3.38

Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci U S A (2002) 3.35

Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliv Rev (2008) 3.34

A secreted luciferase for ex vivo monitoring of in vivo processes. Nat Methods (2008) 3.31

IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells. Proc Natl Acad Sci U S A (2009) 3.31

Expression of Cux-1 and Cux-2 in the subventricular zone and upper layers II-IV of the cerebral cortex. J Comp Neurol (2004) 3.20

Intravital imaging. Cell (2011) 3.18

Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J Exp Med (2003) 3.00

Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J Exp Med (2012) 2.92

Multivalent effects of RGD peptides obtained by nanoparticle display. J Med Chem (2006) 2.91

MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res (2007) 2.90

Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis. J Am Coll Cardiol (2010) 2.90

Opinion: the origin of the cancer stem cell: current controversies and new insights. Nat Rev Cancer (2005) 2.89

Near-infrared fluorescence: application to in vivo molecular imaging. Curr Opin Chem Biol (2009) 2.89

The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue. Nat Biotechnol (2002) 2.89

An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nat Mater (2006) 2.84

Somatic activation of AKT3 causes hemispheric developmental brain malformations. Neuron (2012) 2.84

Ultrasensitive clinical enumeration of rare cells ex vivo using a micro-hall detector. Sci Transl Med (2012) 2.82

Repetitive mild brain trauma accelerates Abeta deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis. J Neurosci (2002) 2.80

The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell (2012) 2.78

Dual channel optical tomographic imaging of leukocyte recruitment and protease activity in the healing myocardial infarct. Circ Res (2007) 2.77

Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate. Proc Natl Acad Sci U S A (2004) 2.77

Rapid detection and profiling of cancer cells in fine-needle aspirates. Proc Natl Acad Sci U S A (2009) 2.75

Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses. Proc Natl Acad Sci U S A (2006) 2.72

Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle. Circ Res (2005) 2.67

Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in mice. Gastroenterology (2002) 2.64

In vivo imaging of proteolytic activity in atherosclerosis. Circulation (2002) 2.62

Epidemiology of intracranial meningioma. Neurosurgery (2005) 2.60

Molecular imaging in the clinical arena. JAMA (2005) 2.59

A submillimeter resolution fluorescence molecular imaging system for small animal imaging. Med Phys (2003) 2.58

Focal disruption of the blood-brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery. J Neurosurg (2006) 2.58

miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell (2008) 2.57

Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease. Nat Med (2007) 2.57

Bioorthogonal turn-on probes for imaging small molecules inside living cells. Angew Chem Int Ed Engl (2010) 2.57

Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo. Circulation (2006) 2.56

A 24-year-old woman with intractable seizures: review of surgery for epilepsy. JAMA (2008) 2.55

A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res (2003) 2.55

Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis. Circulation (2008) 2.52

Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat Biotechnol (2002) 2.50

Bioorthogonal chemistry amplifies nanoparticle binding and enhances the sensitivity of cell detection. Nat Nanotechnol (2010) 2.49

One-Pot Synthesis of New Symmetric and Asymmetric Xanthene Dyes. Tetrahedron Lett (2007) 2.49

Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy. Proc Natl Acad Sci U S A (2009) 2.47

Effect of tumor microenvironment modulation on the efficacy of oncolytic virus therapy. J Natl Cancer Inst (2007) 2.46

Near-infrared fluorescent imaging of matrix metalloproteinase activity after myocardial infarction. Circulation (2005) 2.45

Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes. Bioconjug Chem (2002) 2.45

Exchange-coupled magnetic nanoparticles for efficient heat induction. Nat Nanotechnol (2011) 2.45

Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions. Circulation (2011) 2.45

Defining the actual sensitivity and specificity of the neurosphere assay in stem cell biology. Nat Methods (2006) 2.43

Origins of tumor-associated macrophages and neutrophils. Proc Natl Acad Sci U S A (2012) 2.42

PET/MRI of inflammation in myocardial infarction. J Am Coll Cardiol (2012) 2.39

Dynamics of DNA molecules in a membrane channel probed by active control techniques. Biophys J (2003) 2.38

Identification of the target self-antigens in reperfusion injury. J Exp Med (2006) 2.38

Molecular imaging of cardiovascular disease. Circulation (2007) 2.33

Colonic adenocarcinomas: near-infrared microcatheter imaging of smart probes for early detection--study in mice. Radiology (2007) 2.29

Does adjuvant external-beam radiotherapy improve outcomes for nonbenign meningiomas? A Surveillance, Epidemiology, and End Results (SEER)-based analysis. J Neurosurg (2012) 2.29